Breast cancer remains the most commonly diagnosed cancer in women in the UK, with approximately 56,900 new cases each year. This equates to a lifetime risk of 1 in 7 women. While incidence increases with age, breast cancer affects women across the life course and, although rare, also occurs in men.
Recent data highlights changing incidence patterns, persistent inequalities, and the critical importance of early detection through vigilant assessment, timely referral, and patient education.
Breast Cancer Incidence Is Rising in Younger Women
Between 2000 and 2021, the incidence of breast cancer among women aged 30 to 39 increased almost fourfold [4]. Although breast cancer remains more common in older age groups, this rise in younger women is clinically significant.
Between 2017 and 2019, breast cancer accounted for 43 percent of all cancers diagnosed in women aged 25 to 49, reinforcing the need for awareness beyond traditional screening age groups [2][3].
Mortality Trends and Persistent Inequalities
Breast cancer remains the fourth most common cause of cancer mortality in the UK [3].
Although overall mortality has fallen by around 17 percent over the past decade, inequalities remain stark. Women living in the most deprived areas experience 13 percent higher mortality highlighting that improvements in treatment alone are not enough. Access to early diagnosis and timely care remains critical.
Why Early Diagnosis Saves Lives
Survival outcomes strongly correlate with stage at diagnosis. In England, for women diagnosed between 2016 and 2020:
- Stage 1 breast cancer has a 5-year survival rate approaching 100 percent
- Stage 2 disease has around 90 percent 5-year survival
- Stage 4 disease has survival of approximately 25 percent at five years [5]
These stark differences emphasise the importance of recognising symptoms early and ensuring prompt referral pathways.
Risk Factors and Hormonal Considerations
Breast cancer risk is influenced by multiple factors, including:
- Family history and inherited gene mutations such as BRCA1 and BRCA2
- Increasing age
- Alcohol consumption & Smoking
- Obesity and metabolic health
Hormonal factors are particularly relevant in perimenopause and menopause, when women may present with breast symptoms while also considering menopausal hormone therapy. Careful assessment and evidence-based reassurance are essential.
The Role of Primary Care and Specialist Services
For women navigating menopause, joined-up care between primary care, menopause specialists, and breast services is essential in order to
- Identify red-flag symptoms
- Support timely imaging and referral
- Encourage screening uptake among eligible women
- Provide balanced information about risk, symptoms, and treatment
Support at The Menopause Medic
At The Menopause Medic, we support women across Berkhamsted, St Albans, Watford, Hemel Hempstead, Harpenden, Tring, Welwyn Garden City, and beyond. Our consultations provide evidence-based menopause care, careful symptom assessment, and guidance around breast health and hormone therapy.
References
[1] Cancer Research UK. What is breast cancer?
[2] Cancer Research UK. Cancer incidence by age.
[3] Cancer Research UK. Breast cancer statistics.
[4] Barclay NL et al. Trends in incidence, prevalence and survival of breast cancer in the UK 2000–2021. Scientific Reports. 2024.
[5] Cancer Research UK. Survival for breast cancer.